ArticleFrontiers in artificial intelligence2026
A novel diffuse liver nodule detector via integrating semantic edge features and probabilistic uncertainty modeling.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Ultrasound image segmentation of diffuse liver fibrosis nodules confronts three critical challenges: boundary ambiguity caused by gradual tissue transitions, texture heterogeneity arising from fibrotic variations, and inadequate uncertainty quantification, which manifests as overconfident misclassifications at fibrotic nodules. Methods: To address these challenges, this paper proposes the Edge-Semantics Probabilistic Dirichlet Network (ESPD-Net), which integrates Dirichlet evidential theory into diffuse lesion segmentation for nodule detection. ESPD-Net employs three synergistic components: (1) The Semantic-Probabilistic Dual Path Fusion (SPDF) bottleneck constructs parallel semantic and probabilistic pathways to capture local morphological and global distribution features. (2) The Dirichlet Evidential Guided Decoder (DEGD) reformulates segmentation as second-order probabilistic modeling under evidential theory, guiding the adaptive feature decoding process by outputting calibrated uncertainty distributions. (3) Guided by these localized high-uncertainty regions, the Dirichlet Boundary Aware Refinement (DBAR) module executes targeted geometric corrections to precisely align ambiguous lesion boundaries. Results: Evaluations on murine and clinical datasets demonstrate that ESPD-Net significantly outperforms state-of-the-art methods. Specifically, it achieves a Dice of 0.855 (+0.043) and an IoU of 0.747 (+0.057). Furthermore, the model effectively minimizes calibration and boundary errors, reducing ECE to 3.85% and HD95 to 3.25. Discussion: These findings demonstrate that the proposed ESPD-Net effectively addresses the challenges of diffuse lesion segmentation, thereby objectively confirming its clinical potential for computer-aided diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.